New aspects in placental drug transfer

Israel Medical Association Journal

Volumn 5, Issue 12, 2003, Pages 873-876

  Holcberg, Gershon ^a,b   Tsadkin Tamir, Marina ^a,b   Sapir, Olga ^a,b   Huleihel, Mahmoud ^a,b   Mazor, Moshe ^a,b   Zvi, Zvi Ben ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Hypoglycemic drugs; P glycoprotein; Placenta; Transporters

Indexed keywords

ANTIDIABETIC AGENT; CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; DIGOXIN; DOXORUBICIN; ERYTHROMYCIN; ETOPOSIDE; GLYCOPROTEIN P; HYDROCORTISONE; INSULIN; INSULIN LISPRO; KETOCONAZOLE; MEVINOLIN; MIFEPRISTONE; PACLITAXEL; PROGESTERONE; QUINIDINE; RHODAMINE 123; RITONAVIR; SAQUINAVIR; STEROID; SULFONYLUREA; TAMOXIFEN; UNINDEXED DRUG; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCRISTINE; ZOSUQUIDAR;

BACTERIAL INFECTION; BLOOD PLACENTA BARRIER; CANCER; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COST; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG SAFETY; DRUG TRANSPORT; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MATERNAL PLASMA; MYCOSIS; NONHUMAN; PLACENTA; PLACENTA FUNCTION; PLACENTAL TRANSFER; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRENATAL DRUG EXPOSURE; REVIEW; TERATOGENICITY; UTERUS;

BIOLOGICAL TRANSPORT; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MATERNAL-FETAL EXCHANGE; P-GLYCOPROTEIN; PLACENTA; PREGNANCY;

EID: 0346258348     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Yaffe SJ. Introduction. In: Briggs G, Freeman RK, Yaffe SJ, eds. Drugs in Pregnancy and Lactation. Baltimore: Williams & Wilkins, 1998:xiii-xix.
2. Sastry BV. Techniques to study human placental transport. Adv Drug Deliv Rev 1998;38:17-39.
3. Ganapathy VV, Prasad PD, Ganapathy ME, Leibach FH. Drugs of abuse and placental transport. Adv Drug Deliv Rev 1999;38:99-110.
4. Audus K. Controlling drug delivery across the placenta. Eur J Pharm Sci 1999;8:161-5.
5. Pacifi GM, Nottoli R. Placental transfer of drugs administrated to the mother. Clin Pharmacokinet 1995;28:235-69.
6. Schinkel AH, Joker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview. Adv Drug Deliv Rev 2003;55:3-29.
7. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: The multidrug resistance-associated proteins. J Natl Cancer Inst 2000;92(16):1295-302.
8. St-Pierre MV, Serrano MA, Macias RI, et al. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 2000;279:R1495-503.
9. Gottesman MM, Pastan I, Ambudkar SV. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 1996;6:610-17.
10. Huisman MT, Smit JW, Schinkel AH. Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors. AIDS 2000;14:237-42.
11. Kim RB, Wandel C, Leake B, et al. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res 1999;16:408-14.
12. Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P, Schinkel AH. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest 1997;100:2430-6
13. Fardel O, Lecureur V, Guillouzo A. The P-glycoprotein multidrug transporter. Gen Pharmacol 1996;27:1283-91.
14. Sharom FJ, Liu R, Romsicki Y, Lu P. Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies. Biochim Biophys Acta 1999;1461:327-45.
15. Hoffmeyer S, Burk O, Von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473-8
16. MacFarland A, Abramovich DR, Ewen SWB, Pearson CK. Stage-specific distribution of P-glycoprotein in first trimester and full-term human placenta. Histochem J 1994;26:417-23.
17. Nakaya A, Eguchi O, Hatakeyama M, Saitoh H, Takada M. Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in the rat small intestine. Biol Pharm Bull 1999;22:535-8.
18. Ushigome F, Takanaga H, Matsuo H, et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: Contribution of P-glycoprotein. Eur J Pharmacol 2000;408:1-10.
19. Speroff L, Glass RH, Kase NG. The endocrinology of pregnancy. In: Clinical Gynecologic Endocrinology and Infertility. 6th edn. Baltimore: Lippincott, Williams & Wilkins, 1999;276, 315
20. Woodland C, Ito S, Koren G. A model for prediction of digoxin-drug interactions at the renal tubular cell level. Ther Drug Monit 1998;20:134-8.
21. Holcberg G, Sapir O, Tsadkin M, et al. Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil, in human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 2003;109:133-7
22. Gray RS, Cowan P, Steel JM, Johnstone FD, Clarke BF, Duncan LJ. Insulin action and pharmacokinetics in insulin treated diabetics during the third trimester of pregnancy. Diabet Med 1984;1(4):273-8
23. Keller JM, Krohmer JS. Insulin transfer in the isolated human placenta. Obstet Gynecol 1968;32:77-80.
24. Menon RK, Cohen RM, Sperling MA, Cutfield WS, Mimouni F, Khoury JC. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia. N Engl J Med 1990;323(5):309-15
25. Balsells M, Corcoy R, Mauricio D, et al. Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes. Diabetes Care 1997;20(7):1172-5
26. Holleman F, Hoekstra JB. Insulin lispro. N Engl J Med 1997;337:176-83.
27. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422-7.
28. Masson EA, Patmore JE, Brash PD, et al. Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). Diabet Med 2003;20(1):46-50
29. Boskovic R, Feig DS, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insulin lispro across the human placenta: In vitro perfusion studies. Diabetes Care 2003;26(5):1390-4
30. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343(16):1134-8.
31. Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 1995;118(11):1446-51.
32. Kemball ML, McIver C, Milner RD, Nourse CH, Schiff D, Tiernan JR. Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child 1970;45:696-701.
33. Sutherland HW, Bewsher PD, Cormack JD, et al. Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome. Arch Dis Child 1974:49(4):283-91.
34. Coetzee EJ, Jackson WP. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1985-86:1(5):281-7.
35. Elliott BD, Schenker S, Langer O, Johnson R, Prihoda T Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transfer. Am J Obstet Gynecol 1994;171(3):653-60.
36. Koren G, Glyburide and fetal safety; Transplacental pharmacokinetic considerations. Reprod Toxicol 2001;15(3):227-9.
37. Hellmuth E, Damm P, Molste-Pedersen L. Oral hypoglycemic agents in 118 diabetic pregnancies. Diabet Med 2000;17:507-11.
38. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Continuing metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77:520-5.
39. Coetzee EJ, Jackson WPW. Metformin in management of pregnancy insulin-independent diabetes. Diabetologia 1979;16:241-5.